Serena Williams and the GLP-1 Debate

Serena Williams is back on the court—and with her, a heated debate about GLP-1 weight-loss drugs like Zepbound. Partnering with Ro, she’s candid about losing 34 pounds and regaining energy, but her use sparks controversy as WADA watches these meds closely. Not banned yet, but under scrutiny—could they give athletes an edge? Her personal journey fuels the conversation as she navigates fitness, performance, and the science behind these controversial treatments. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/66f657b8ebbb9437